Release Date: 23/11/16 15:57 Summary: Annual General Meeting Results - 2016 Price Sensitive: No Download Document 218.07KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%